is there still a glp-1 shortage 📢 FDA has determined the of semaglutide injection products, glucagon-like peptide 1 (GLP-1) medication, resolved. Patients and prescribers may see intermittent and limited localized supply disruptions as the GLP-1/GIP Shortage Updates | OrderlyMeds

Sleep , because poor sleep blunts appetite regulation and undermines every other effort

Abstract Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body mass index, and adverse cardiovascular events

Millions of customers trust us to help them get in shape

CrossRef Immune Determinants of MASLD Progression: From Immunometabolic Reprogramming to Fibrotic Transformation Senping Xu, Zhaoshan Zhang, Zhongquan Zhou, Jiawei Guo Biology.2026

In contrast, studies on human senior subjects show that low IGF-1 levels are associated with poor knee extensor muscle strength, slow walking speed, and difficulty with mobility tasks [6]